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Zebrafish dracula encodes ferrochelatase and its mutation
provides a model for erythropoietic protoporphyria
Sarah Childs*†, Brant M. Weinstein*†‡, Manzoor-Ali P.K. Mohideen*§, 
Susan Donohue*¶, Herbert Bonkovsky*¶ and Mark C. Fishman*
Exposure to light precipitates the symptoms of several
genetic disorders that affect both skin and internal
organs. It is presumed that damage to non-cutaneous
organs is initiated indirectly by light, but this is difficult
to study in mammals. Zebrafish have an essentially
transparent periderm for the first days of development.
In a previous large-scale genetic screen we isolated a
mutation, dracula (drc), which manifested as a light-
dependent lysis of red blood cells [1]. We report here
that protoporphyrin IX accumulates in the mutant
embryos, suggesting a deficiency in the activity of
ferrochelatase, the terminal enzyme in the pathway for
heme biosynthesis. We find that homozygous drcm248
mutant embryos have a G→T transversion at a splice
donor site in the ferrochelatase gene, creating a
premature stop codon. The mutant phenotype, which
shows light-dependent hemolysis and liver disease, is
similar to that seen in humans with erythropoietic
protoporphyria, a disorder of ferrochelatase.
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Results and discussion
In a large-scale mutant screen we identified several classes
of recessive lethal mutations with reduced numbers of or
no red blood cells [1]. One subset, including drc, exhibits a
far more pronounced anemia when raised under standard
ambient light conditions than if raised in the dark. We iso-
lated four alleles of drc: drcm87, drcm248 and drcm328 lack
blood entirely four days post-fertilization (4 dpf) when raised
under normal light, and drcm159 has only a few circulating
cells at that time [1]. drc erythrocytes are strongly fluorescent
when exposed to epifluorescent illumination using a rho-
damine filter (peak illumination at 510–560 nm). Upon illu-
mination, red cells immediately begin to lyse within the
blood vessels, and completely disappear within 2 minutes
(Figure 1a). Under standard microscopic white light illumi-
nation, the lysis proceeds more slowly, and takes
15–20 minutes to be complete. Rapid erythrocyte lysis has
other detrimental effects upon the embryo, manifest as
bradycardia and diminished cardiac contractility. This
appears to depend on the acuity of hemolysis, as embyros of
Figure 1
Blood and liver phenotypes of drc mutant zebrafish. (a) Time-lapse
series showing autofluorescent erythrocytes in the trunk of 1 dpf
drcm248 embryos visualized under fluorescent light with a rhodamine
filter (peak illumination at 510–560 nm). Circulation was arrested by
use of Tricaine. By 120 sec, all erythrocytes have lysed. (b) Side view of
6 dpf drcm248 mutant and wild-type (WT) larvae under white light (top
panels) and fluorescent light (bottom panels). The reddish liver in the
mutants has a large number of red-brown inclusions that autofluoresce.
(c) Cross-sections of 6 dpf drcm248 mutant and wild-type embryos
under fluorescent (left) and Nomarski (right) optics. Mutants show
extensive autofluorescence in the liver, and pronephric ducts but not in
other tissues. For sectioning, embryos were fixed in paraformaldehyde,
dehydrated in an ethanol series and embedded in JB4 medium
(Polysciences). Sections 5 µm thick were mounted without coverslips
and viewed with a rhodamine filter to detect autofluorescence. d,
pronephric duct; g, gut; l, liver; nc, notochord; nt neural tube; s, somite.
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the same age exposed chronically to low light levels from
birth have a similar degree of anemia, but without abnormal
heart rate or contractility.
The liver of drcm248 mutant embryos shows several hepatic
abnormalities. It has a red hue and many inclusions are
visible under both white and fluorescent light (Figure 1b).
The cells are pleiomorphic and show variable histological
atypia (data not shown). The hepatic inclusions are not
limited to the region of vessels, but are scattered through-
out the parenchyma (Figure 1c). In drcm248, these hepatic
inclusions accumulate even in dark-raised embryos. We
also observed fluorescent inclusions in the pronephric
ducts of 6 dpf drcm248 embryos. At 4 dpf, the zebrafish
kidney becomes a major site of erythropoiesis, and thus
the accumulation of fluorescence there is likely to be due
to the presence of erythrocytes in the tissue.
The phenotype of drc mutants is suggestive of a group of
disorders known as porphyrias in humans, which are caused
by mutations in enzymes of the heme biosynthetic pathway.
The sequential actions of eight enzymes generate heme, a
pathway initiated by condensation of glycine and succinyl
CoA into δ-aminolevulinate. Defects in the last five
enzymes of the pathway are accompanied by accumulation
of porphyrin intermediates. Illumination of these highly
light-sensitive compounds causes the production of singlet
oxygen and free radicals, leading, among other effects, to
lipid peroxidation [2,3]. Patients show a constellation of
symptoms which vary among porphyrias. They include
cutaneous sensitivity to light, hemolysis of autofluorescent
red blood cells and hepatic pathology. A phenotype similar
to that of drc has been observed in the zebrafish mutation
yquem, which has a mutation in uroporphyrinogen decar-
boxylase, an enzyme in this pathway [4]. drc is, by comple-
mentation analysis, a different gene from yquem. 
We examined porphyrin levels in drcm87 embryos by
HPLC. One porphyrin in particular, protoporphyrin IX, is
present at very high levels in drc mutant embryos (Figure 2)
whereas it is nearly undetectable in a pool of wild-type
and heterozygous embryos. This suggested that the muta-
tion in drc mutant embyros might lie in the ferrochelatase
(fch) gene, which encodes an enzyme that converts proto-
porphyrin IX into heme by catalyzing the transfer of iron
to the heme moiety. 
In humans, mutations in fch cause the disorder erythropoi-
etic protoporphyria (EPP; OMIM entry 177000). Patients
have autofluorescent, light-sensitive red cells, and some
develop severe liver disease. In humans, red cells are
thought to be exposed to light during their transit through
the skin, and it is presumed that the liver is damaged by
uptake of toxic substances released by their lysis, as well
as from local synthesis of protoporphyrin [5]. Crystalline
deposits of protoporphyrin have been observed in the
livers of patients with EPP [6]. The inclusions we observe
in the liver of 6 day drc mutants may be similar to these,
although they appear not to be biorefringent, and may
represent a stage before the formation of large crystals. 
To determine whether fch is mutated in drc we first cloned
the wild-type zebrafish gene. The cDNA is 1405 bp long
and encodes a putative 409-amino-acid protein (GenBank
accession number AF250368). The predicted protein
sequence is highly conserved through evolution, with a
>80% identity to human and other vertebrate fer-
rochelatases, 57% identity to the Drosophila gene, and 50%
identity to the Saccharomyces cerevisiae gene. 
In situ hybridization shows that expression of fch in the
lateral plate mesoderm begins early in development, around
the 9–10 somite (S) stages. This is later than the early
hematopoietic markers GATA2 and GATA1 [7], but con-
temporaneous with other markers of differentiated erythro-
cytes, such as aminolevulinate synthase (ALAS) [8]. At this
time, cells which will adopt a hematopoietic fate are inter-
spersed in the lateral plate with cells which will become
vessel and pronephric duct. In fact, there may be a shared
common precursor cell for the first intra-embryonic blood
and angioblasts, a cell tentatively called the hemangioblast
[9]. flk-1, fli-1 and scl are expressed by both hematopoietic
and angioblast lineages [10,11]. At the 9–10S stage, fch is
expressed in the trunk (but not the head) of the zebrafish
embryo in a pattern similar to these other markers
(Figure 3). By the 14S stage, fch-expressing cells of the
lateral plate have begun to migrate in a pattern similar to
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Figure 2
Protoporphyrin IX content of drcm248 mutant (fluorescent) and
heterozygous or wild-type (non-fluorescent) embryos. Protoporphyrin
content is measured in µg/mg protein ± SD. Free protoporphyrin was
extracted with ethanol from 500 fluorescent and 500 non-fluorescent
drcm87 embryos at 3 dpf and assayed by HPLC. We confirmed that all
of the porphyrin found by spectrofluorimetric assays (excitation
wavelength = 402 nm; emission = 632 nm) was protoporphyrin by our
standard HPLC assay [17].
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that of GATA1 and GATA2 and distinct from that of
angioblastic markers. This medial migration progresses tem-
porally from anterior to posterior. By 24 hours development
fch-expressing cells begin circulating, and it becomes clear
that the expression of fch is then restricted to erythrocytes.
Genetic and radiation hybrid mapping place the drc muta-
tion and the fch gene within 0.1 centimorgans (cM) of each
other on linkage group 21 within a 3.4 cM interval defined
by markers Z6295 and Z4718. drc is 1.2 cM from the closest
marker Z4718. Therefore, we isolated and sequenced fch
cDNA and genomic DNA sequences from drc mutant
embryos (Figure 4). We find that drcm248 has a point muta-
tion, a G→T transversion, located in a 5′ splice donor
sequence, preventing the excision of intron sequence.
Interestingly, this splice site is conserved in position with
the exon 4 splice donor site in the human fch gene [12],
but no equivalent human mutation has been reported.
The unexcised intron sequence begins with the stop
codon TAA, which is in-frame with the fch translation.
Thus, the effect of the mutation is to cause premature
chain termination (91 amino acids instead of 409). A
cryptic splice donor site located 27 base pairs (bp) down-
stream in the unexcised intron sequence is used to splice
the mutant exon to the normal 3′ acceptor sequence so
that the cDNA of fch from drcm248 is 1432 bp, 27 bp longer
than the wild-type cDNA. Given that the first 55 amino
acids of fch are known to encode leader sequences for
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Figure 3
Expression of fch in wild-type and mutant
embryos. fch is expressed in the posterior
lateral plate mesoderm of embryos before
erythropoietic precursors have migrated to
the midline as early as the 9 somite (S)
stage. fch-expressing cells (brown) begin
to migrate medially at 12–14S in a segmental
fashion, and form a wide single stripe at the
midline. At 24 hpf, cells expressing fch are
in the vein and artery, with the majority of
cells in the vein. No expression of fch is
detected in any other tissues up to 48 hpf.
(a) 10S; (b) 14S; (c) 15S; (d) 17S; (e,f) 24
hpf side and dorsal view. (g) An embryo at
24 hpf in which circulation has begun shows
fch expression in cells over the yolk in the
ducts of Cuvier. Anterior is to the left. For
the in situ hybridization, fch was digested
with HindIII and transcribed from T7. The
probe was hybridized as previously
described [18].
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Figure 4
Alignments of genomic DNA and cDNA from
the fch gene of drcm248 and wild-type
embryos show a point mutation (arrow and
boldface) at a splice donor site in genomic
DNA, resulting in a 27 bp insertion of intron
sequence into the cDNA. An in-frame stop
codon in the insertion in the intron sequence
(underlined) truncates the predicted protein-
coding sequence. A cryptic splice donor
sequence 27 bp into the intron is used to
splice the cDNA to the correct downstream
exon, and thereby continue cDNA
transcription to the normal polyadenylation
site. The predicted protein sequence of fch in
drcm248 is truncated with respect to the wild-
type protein. Predicted binding sites for the
iron-sulfur cluster in the wild-type protein are
underlined. The conservative amino-acid
substitution at amino acid 84 is due to a
polymorphism in the AB strain.
Genomic DNA 
Mutation
m248  –/– TCATGCAGCTGCCCGTGCAAAATTAAGAAAGACTATTCAACATTTATAGGTCTAATATATACACTTCCTGAC|||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||
WT TCATGCAGCTGCCCGTGCAAAAGTAAGAAAGACTATTCAACATTTATAGGTCTAATATATACACTTCCTGAC
cDNA Exon ExonIntron sequence
m248  –/– TCATGCAGCTGCCCGTGCAAAATTAAGAAAGACTATTCAACATTTATAGTAAACTCGGGCCATTCATTGCCA
||||||||||||||||||||||                           |||||||||||||||||||||||
WT
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TCATGCAGCTGCCCGTGCAAAA...........................TAAACTCGGGCCATTCATTGCCA
Predicted protein
m248  –/– MAVLGGACRLVQLVRCGSPVGLCLSSSLRRQSTATAAAFNTTATPETKESRKPKTGILML
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WT MAVLGGACRLVQLVRCGSPVGLCLSSSLRRQSTATAAAFNTTATPETKESRKPKTGILML
m248  –/–
||||||||||||||||||||||| |||||||
WT
WT WTTMQGEGMVKLLDEMCPDTAPHKFYIGFRYVHPLTEEAIELMEKDGVERAVAFTQYPQY
WT SCSTTGSSLNAIYRYYSNRADRPKMRWSVIDRWPTHPLLIECFAEHVRNELDKFPVEKRD
WT DVVILFSAHSLPLSVVNRGDPYPQEVGATVQRVMDRLGHCNPYRLVWQSKVGPMAWLGPQ
WT TDEVIKGLCQRGKRNLLLVPIAFTSDHIETLHELDIEYSQVLGEEVGVENIRRAESLNGN
WT
Mutation
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PLFFRALADLVQSHLQSNESCSRQLTLRCPLCVNPTCAQTKAFFSSQKL 409
NMGGPEKLEDVHDFLLRLFMDTDLMQLPVQN*
NMGGPEKLEDVHDFLLRLFMDTDFMQLPVQNKLGPFIAKRRTPKIQEQYSKIGGGSPIKA
mitochondrial insertion, and are unconserved even among
closely related species, we expect that the short peptide of
fch in drcm248 would be a functional null. In particular, it is
known that the 2Fe⋅2S cluster, which is encoded down-
stream of the mutation in the carboxyl terminus of fch, is
absolutely necessary for the activity of vertebrate fer-
rochelatases. This cluster would be completely absent in
drcm248 ferrochelatase. A critical histidine residue would
also be missing in the truncated peptide [13].
Heme is a component of many essential cellular proteins
in addition to ferrochelatase. This suggests that some
heme or ferrochelatase activity must be present during
early embryonic stages, before heme synthesis begins in
the wild-type embyro. The survival of our apparently null
fch mutants to early larval stages also implies an early
source of heme independent of ferrochelatase activity. As
we have found no evidence of a second fch gene in the
zebrafish genome, and, using the reverse transcription and
polymerase chain reaction (RT-PCR), did not find evi-
dence for any residual correct splicing, we propose that
there are maternally deposited stores of either heme, fch
mRNA, or ferrochelatase protein in the yolk of the
embryo. This is not unprecedented, as the zebrafish yolk
is a store for the iron required for early hemoglobin syn-
thesis [14], as well as for mRNAs that make a significant
contribution to early development [15,16].
This work emphasizes the potential relevance of genome-
wide mutational analysis in zebrafish to heritable human
disease. As a model of EPP, the transparency and accessi-
bility of the early zebrafish embryo permits studies of pro-
toporphyrin-induced developmental organ toxicity under
controlled light conditions. This ability can be exploited
to evaluate the light dependence of organotypic pheno-
types, an approach complementary to studies in mice and
tissue culture cells [3,5]. In the future, drc mutant zebrafish
might be used for direct in vivo screening to discover
chemical agents which might be useful for preventing or
ameliorating the symptoms of EPP in humans. 
Supplementary material
Supplementary material including additional methodological detail is
available at http://current-biology.com/supmat/supmatin.htm.
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